MMV-390048 - 97%, high purity , CAS No.1314883-11-8

Item Number
M173331
Grouped product items
SKUSizeAvailabilityPrice Qty
M173331-1mg
1mg
3
$39.90
M173331-5mg
5mg
3
$162.90
M173331-25mg
25mg
3
$543.90
M173331-50mg
50mg
2
$870.90
M173331-100mg
100mg
2
$1,360.90

Basic Description

Synonyms0Z5T00JJ10 | AKOS030628490 | SCHEMBL2225969 | 3-(2-(Trifluoromethyl)pyridin-5-yl)-5-(4-(methylsulfonyl)- phenyl)pyridin-2-amine | MMV390048 | MMV-390048 | J3.367.891F | HY-106005 | 5-(4-(Methylsulfonyl)phenyl)-6'-(trifluoromethyl)-[3,3'-bipyridin]-2-amine
Specifications & PurityMoligand™, ≥97%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Product Description

Product Describtion:

MMV-390048, an antimalarial agent, is an inhibitor of Plasmodium PI4K with Kd of 0.3 μM.

AI Insight

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid504771141
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504771141
IUPAC Name 5-(4-methylsulfonylphenyl)-3-[6-(trifluoromethyl)pyridin-3-yl]pyridin-2-amine
INCHI InChI=1S/C18H14F3N3O2S/c1-27(25,26)14-5-2-11(3-6-14)13-8-15(17(22)24-10-13)12-4-7-16(23-9-12)18(19,20)21/h2-10H,1H3,(H2,22,24)
InChi Key RTJQABCNNLMCJF-UHFFFAOYSA-N
Canonical SMILES CS(=O)(=O)C1=CC=C(C=C1)C2=CC(=C(N=C2)N)C3=CN=C(C=C3)C(F)(F)F
Isomeric SMILES CS(=O)(=O)C1=CC=C(C=C1)C2=CC(=C(N=C2)N)C3=CN=C(C=C3)C(F)(F)F
PubChem CID 53311393
Molecular Weight 393.383

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
C2209178Certificate of AnalysisDec 06, 2024 M173331
C2209593Certificate of AnalysisDec 06, 2024 M173331
C2209594Certificate of AnalysisDec 06, 2024 M173331
C2209597Certificate of AnalysisDec 06, 2024 M173331
C2209598Certificate of AnalysisDec 06, 2024 M173331

Related Documents

Reviews

Customer Reviews

References

1. Younis Y, Douelle F, Feng TS, González Cabrera D, Le Manach C, Nchinda AT, Duffy S, White KL, Shackleford DM, Morizzi J et al..  (2012)  3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential..  J Med Chem,  55  (7): (3479-87).  [PMID:22390538] [10.1021/op500134e]
2. Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, Lee MCS, Basak R, Ghidelli-Disse S, Lafuente-Monasterio MJ et al..  (2017)  Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase..  Sci Transl Med,  (387): (1755-70).  [PMID:28446690] [10.1021/op500134e]
3. McCarthy JS, Donini C, Chalon S, Woodford J, Marquart L, Collins KA, Rozenberg FD, Fidock DA, Cherkaoui-Rbati MH, Gobeau N et al..  (2020)  A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048..  Clin Infect Dis,  71  (10): (e657-e664).  [PMID:32239164] [10.1021/op500134e]
4. McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ et al..  (2013)  Targeting Plasmodium PI(4)K to eliminate malaria..  Nature,  504  (7479): (248-253).  [PMID:24284631] [10.1021/op500134e]

Solution Calculators